very little of what she said actually panned out.
I just think back to how poorly Thyramir was launched. She set an arbitrary date based on little experience and overall ignorance of the process of launching a diagnostic test, but we were able to say we launched it on the date she said we would.
Minus the study being published
without the ability to leave behind any literature or information
no reimbursement details
We have a better test than anything else on the market, but you only get one chance to launch and we blew it. When CBLpath publishes their data we are toast because we didn't build a big enough base of business in the nine months we've been selling this stuff.
